학술논문
A decreased Level of Shp1 provides an additive survival advantage to the Ph+ Cells of CML Patients and may account for Resistance to Imatinib Treatment
Document Type
Abstract
Author
Esposito, Nicola ; Colavita, Irene ; Quarantelli, Fabrizio ; Izzo, Barbara ; Luciano, Luigia; Vecchio, Luigi Del ; Hughes, Timothy; Radich, Jerald ; Russo, Domenico; Soverini, Simona ; Iacobucci, Ilaria ; Martinelli, Giovanni ; Saglio, Giuseppe ; Melo, Junia ; Ruoppolo, Margherita ; Kalebic, Thea ; Pane, Fabrizio
Source
In Blood 16 November 2008 112(11):3186-3186
Subject
Language
ISSN
0006-4971